Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular and molecular features related to exceptional therapy response and extreme long‐term survival in glioblastoma
Brecht Decraene, Maxime Vanmechelen, Paul M. Clément, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11107-11126
Open Access | Times Cited: 13

Showing 13 citing articles:

Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)
Iulia Peciu-Florianu, Quentin Vannod‐Michel, Enora Vauleon, et al.
Journal of Neuro-Oncology (2024) Vol. 168, Iss. 3, pp. 495-505
Open Access | Times Cited: 5
Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma
Alisa B. Ageenko, Natalia S. Vasileva, Vladimir A. Richter, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2042-2042
Open Access | Times Cited: 4
Single‐cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma
Lise Finotto, Basiel Cole, Wolfgang Giese, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 11
Open Access | Times Cited: 9
Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?
Anne Clavreul, Catherine Guette, Hamza Lasla, et al.
Molecular Oncology (2024) Vol. 18, Iss. 11, pp. 2783-2800
Open Access | Times Cited: 3
Bioactive compounds from Actinidia arguta fruit as a new strategy to fight glioblastoma
Catarina Macedo, Paulo Costa, Francisca Rodrigues
Food Research International (2023) Vol. 175, pp. 113770-113770
Open Access | Times Cited: 6
A novel methylation signature predicts extreme long-term survival in glioblastoma
Brecht Decraene, Grégoire Coppens, Lien Spans, et al.
Journal of Neuro-Oncology (2024) Vol. 169, Iss. 2, pp. 341-347
Open Access | Times Cited: 1
Standardizing analysis of intra‐tumoral heterogeneity with computational pathology
Ameesha Paliwal, Kevin Faust, Azhar Alshoumer, et al.
Genes Chromosomes and Cancer (2023) Vol. 62, Iss. 9, pp. 526-539
Open Access | Times Cited: 1
Spatial single-cell profiling of deeply matched extreme long-term surviving glioblastoma patients reveals a distinct immune and stem cell driven ecosystem
Brecht Decraene, Asier Antoranz, Maxime Vanmechelen, et al.
Research Square (Research Square) (2024)
Open Access
Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)
Iulia Peciu-Florianu, Quentin Vannod‐Michel, Enora Vauleon, et al.
Research Square (Research Square) (2024)
Open Access
Novel Approaches to Treat Glioblastoma Multiforme
Mark G. Malkin, Laurence Booth, Jane L. Roberts, et al.
EMJ Oncology (2024), pp. 110-115
Open Access
Inovações no tratamento do Glioblastoma pela patologia molecular: Uma Revisão Bibliográfica
Luiza Buchemi Cardoso, Clarisse Bezri Hermont, Elisa Penna Bastos, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 9, pp. e75852-e75852
Open Access
Single-cell profiling and zebrafish avatars revealLGALS1as immunomodulating target in glioblastoma
Lise Finotto, Basiel Cole, Wolfgang Giese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top